Efficacy and safety findings from MANTRA: A global, randomized, multicenter, phase III study of the MDM2 inhibitor milademetan vs trabectedin in patients with dedifferentiated liposarcomas Meeting Abstract
| Authors: | Chen, T. W. W.; Sanfilippo, R.; Jones, R. L.; Schuetze, S. M.; Sebio Garcia, A.; Alvarez, R. M.; Bui, N.; Ahn, J. H.; Loong, H. H. F.; Yen, C. C.; Hong, J. Y.; Kim, H. S.; Patel, S.; Bryce, R. P.; Xu, F.; Zhang, B.; Shah, N. V.; Doebele, R. C.; Schwartz, G.; Gounder, M. |
| Abstract Title: | Efficacy and safety findings from MANTRA: A global, randomized, multicenter, phase III study of the MDM2 inhibitor milademetan vs trabectedin in patients with dedifferentiated liposarcomas |
| Meeting Title: | ESMO Asia Congress 2023 |
| Journal Title: | Annals of Oncology |
| Volume: | 34 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2023 Dec 1-3 |
| Meeting Location: | Singapore |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2023-11-01 |
| Start Page: | S1496 |
| Language: | English |
| ACCESSION: | WOS:001122475400079 |
| DOI: | 10.1016/j.annonc.2023.10.211 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 76MO -- Source: Wos |
